![Valerie M. Mulligan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Valerie M. Mulligan
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Neose Technologies, Inc.
![]() Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.
22
| Extinct | Pharmaceuticals: Major | 22 |
Ethicon, Inc.
![]() Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ.
6
| Subsidiary | Medical Specialties | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Valerie M. Mulligan via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
U.S. Bioscience, Inc.
![]() U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Biotechnology | Director of Finance/CFO President | |
MedImmune Vaccines, Inc.
![]() MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Biotechnology | President Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree | |
The Pennsylvania State University | College/University | Corporate Officer/Principal Doctorate Degree | |
Purdue University | College/University | Doctorate Degree Doctorate Degree | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Corporate Officer/Principal | |
National Venture Capital Association
![]() National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
NOVADEL PHARMA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ethicon Endo-Surgery, Inc.
![]() Ethicon Endo-Surgery, Inc. Medical SpecialtiesHealth Technology Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH. | Medical Specialties | Sales & Marketing Corporate Officer/Principal | |
The Wistar Institute
![]() The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | Director/Board Member Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
The Biotechnology Institute
![]() The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Woods Services, Inc.
![]() Woods Services, Inc. Medical/Nursing ServicesHealth Services Woods Services, Inc. provides health, education, housing, workforce, behavioral health and case management services. The company was founded by Mollie Woods in 1913 and is headquartered in Langhorne, PA. | Medical/Nursing Services | Director/Board Member | |
The Marine Biological Laboratory
![]() The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Miscellaneous Commercial Services | Director/Board Member | |
TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Pharmaceuticals: Major | Director/Board Member | |
Princeton University | College/University | Undergraduate Degree | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
University of Calgary | College/University | Graduate Degree | |
Marist College | College/University | Undergraduate Degree | |
USCI, Inc.
![]() USCI, Inc. Wireless TelecommunicationsCommunications USCI, Inc. engages in marketing of telecommunications products and services with an emphasis on two principal markets: Internet telephony products and services and wireless services. The company also engages in the delivery of web-based accounts receivable management and recovery services through its subsidiaries. The company was founded in May 1995. | Wireless Telecommunications | President | |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Chairman | |
Radiant Medical, Inc.
![]() Radiant Medical, Inc. Pharmaceuticals: MajorHealth Technology Radiant Medical, Inc. develops and manufactures endovascular temperature therapy products. Its products are used for the treatment of radiocontrast nephropathy, heart attack, and cardiac arrest. The company was founded in 1997 and is located in Redwood City, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Cynvec LLC
![]() Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Knoll Pharmaceutical Co. | Corporate Officer/Principal | ||
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Takeda Vaccines (Montana), Inc.
![]() Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Chairman | |
NovaDigm Therapeutics, Inc.
![]() NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chairman | |
RainDance Technologies, Inc.
![]() RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
The University of Michigan Law School | College/University | Graduate Degree | |
Intact Vascular, Inc.
![]() Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | Medical Specialties | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 49 |
Canada | 3 |
Sectoraal
Health Technology | 28 |
Consumer Services | 12 |
Commercial Services | 6 |
Health Services | 2 |
Distribution Services | 2 |
Operationeel
Director/Board Member | 146 |
Corporate Officer/Principal | 60 |
Chairman | 35 |
Independent Dir/Board Member | 32 |
President | 29 |
Sterkste connecties
Insiders | |
---|---|
Brian H. Dovey | 40 |
Paul Neff | 33 |
Mark Rachesky | 30 |
Leonard Patrick Gage | 26 |
H. Parker | 22 |
Robert W. Croce | 21 |
Kathryn Gregory | 16 |
C. Boyd Clarke | 15 |
Kenneth G. Hayes | 13 |
William F. Hamilton | 13 |
Elizabeth Hamilton Seabury Wyatt | 11 |
A. Davis | 10 |
Bill Hoffman | 9 |
Joseph J. Villafranca | 9 |
Michael P. Whitman | 9 |
- Beurs
- Insiders
- Valerie M. Mulligan
- Bedrijfsconnecties